Boris A. Czeskis

430 total citations
35 papers, 328 citations indexed

About

Boris A. Czeskis is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Boris A. Czeskis has authored 35 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Boris A. Czeskis's work include Synthetic Organic Chemistry Methods (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Cyclopropane Reaction Mechanisms (5 papers). Boris A. Czeskis is often cited by papers focused on Synthetic Organic Chemistry Methods (10 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Cyclopropane Reaction Mechanisms (5 papers). Boris A. Czeskis collaborates with scholars based in United States, Russia and Sweden. Boris A. Czeskis's co-authors include Barry M. Trost, William J. Wheeler, О. М. Нефедов, A. M. Moiseenkov, Trent L. Abraham, Kenneth C. Cassidy, Gregory R. Luedtke, Minxia M. He, William R. Bartlett and William S. Johnson and has published in prestigious journals such as Diabetes, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Boris A. Czeskis

35 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris A. Czeskis United States 11 190 90 43 43 38 35 328
Kasimir K. Pivnitsky Russia 12 264 1.4× 159 1.8× 37 0.9× 20 0.5× 52 1.4× 61 418
Paul Barraclough United Kingdom 11 263 1.4× 91 1.0× 35 0.8× 16 0.4× 32 0.8× 40 330
Elisa I. León Spain 14 390 2.1× 103 1.1× 23 0.5× 61 1.4× 23 0.6× 34 433
Marie Elise Tran Huu Dau France 11 333 1.8× 156 1.7× 46 1.1× 20 0.5× 30 0.8× 13 435
Kevin E. Henegar United States 12 267 1.4× 137 1.5× 36 0.8× 20 0.5× 19 0.5× 20 372
M. T. NUNEZ Spain 7 284 1.5× 80 0.9× 41 1.0× 18 0.4× 17 0.4× 8 338
Brandon R. Smith United States 5 289 1.5× 56 0.6× 23 0.5× 39 0.9× 19 0.5× 5 357
Irma Panfil Poland 14 425 2.2× 160 1.8× 36 0.8× 59 1.4× 32 0.8× 34 511
A. J. POSS United States 13 305 1.6× 102 1.1× 44 1.0× 132 3.1× 18 0.5× 26 414
Yoshiya Amemiya Japan 11 237 1.2× 120 1.3× 39 0.9× 16 0.4× 15 0.4× 14 348

Countries citing papers authored by Boris A. Czeskis

Since Specialization
Citations

This map shows the geographic impact of Boris A. Czeskis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris A. Czeskis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris A. Czeskis more than expected).

Fields of papers citing papers by Boris A. Czeskis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris A. Czeskis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris A. Czeskis. The network helps show where Boris A. Czeskis may publish in the future.

Co-authorship network of co-authors of Boris A. Czeskis

This figure shows the co-authorship network connecting the top 25 collaborators of Boris A. Czeskis. A scholar is included among the top collaborators of Boris A. Czeskis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris A. Czeskis. Boris A. Czeskis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morse, Bridget L., Shobha Bhattachar, Xiaosu Ma, et al.. (2025). Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants. Clinical Pharmacology in Drug Development. 15(1). e1594–e1594. 1 indexed citations
2.
Martin, Jennifer A., Boris A. Czeskis, Shweta Urva, & Kenneth C. Cassidy. (2024). Absorption, distribution, metabolism, and excretion of tirzepatide in humans, rats, and monkeys. European Journal of Pharmaceutical Sciences. 202. 106895–106895. 6 indexed citations
3.
Martin, Jennifer, et al.. (2020). 940-P: 14C-Tirzepatide ADME Studies in Rat and Monkey. Diabetes. 69(Supplement_1). 2 indexed citations
4.
Czeskis, Boris A., Charles S. Elmore, Anthony R. Haight, et al.. (2019). Deuterated active pharmaceutical ingredients: A science‐based proposal for synthesis, analysis, and control. Part 1: Framing the problem. Journal of Labelled Compounds and Radiopharmaceuticals. 62(11). 690–694. 21 indexed citations
5.
Norman, Bryan H., Matthew J. Fisher, Boris A. Czeskis, et al.. (2018). Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury. Journal of Medicinal Chemistry. 61(5). 2041–2051. 22 indexed citations
6.
7.
Czeskis, Boris A. & William J. Wheeler. (2005). Synthesis of β3 adrenergic receptor agonist LY377604 and its metabolite 4‐hydroxycarbazole, labeled with carbon‐14 and deuterium. Journal of Labelled Compounds and Radiopharmaceuticals. 48(6). 407–419. 14 indexed citations
8.
Czeskis, Boris A., et al.. (2004). Synthesis of 14C‐labeled and tritiated AMPA potentiator LY450108. Journal of Labelled Compounds and Radiopharmaceuticals. 48(2). 85–100. 4 indexed citations
9.
He, Minxia M., Trent L. Abraham, Thomas J. Lindsay, et al.. (2003). Metabolism and Disposition of the Antihypertensive Agent Moxonidine in Humans. Drug Metabolism and Disposition. 31(3). 334–342. 7 indexed citations
10.
Wirth, David D., Minxia M. He, Boris A. Czeskis, et al.. (2002). Identification, synthesis and pharmacological activity of moxonidine metabolites. European Journal of Medicinal Chemistry. 37(1). 23–34. 1 indexed citations
11.
12.
He, Minxia M., et al.. (2000). Metabolism and Disposition of Moxonidine in Fischer 344 Rats. Drug Metabolism and Disposition. 28(4). 446–459. 10 indexed citations
13.
14.
15.
Czeskis, Boris A., et al.. (1993). Total Synthesis of the Archaebacterial C40-Diol and its Enantiomer Based on(R)-5-Acetoxy-4-methylpentanoic Acid. Mendeleev Communications. 3(3). 93–96. 6 indexed citations
16.
Czeskis, Boris A., et al.. (1993). Efficient Synthesis of (S,Z)-Dodec-3-en-11-olide (Ferrulactone II) using 2-Carboxyethyltriphenylphosphonium Bromide. Mendeleev Communications. 3(3). 96–97. 16 indexed citations
17.
Czeskis, Boris A., et al.. (1989). New synthesis of perillene and some other furanoterpenes by cyclopropylcarbinyl rearrangement. Russian Chemical Bulletin. 38(1). 131–134. 3 indexed citations
18.
Czeskis, Boris A., et al.. (1986). Synthesis of some monoterpenols via cyclopropylcarbinyl rearrangement. Collection of Czechoslovak Chemical Communications. 51(6). 1316–1322. 5 indexed citations
19.
Czeskis, Boris A., et al.. (1982). Synthesis of (±)-hotrienol and (±)-santolina alcohol via cyclopropenes. Journal of the Chemical Society Chemical Communications. 109–110. 5 indexed citations
20.
Czeskis, Boris A., et al.. (1981). Cyclopropenylcarbinyl-allenyl rearrangement. Tetrahedron Letters. 22(2). 151–154. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kasimir K. Pivnitsky Breakdown of academic impact, for papers by Paul Barraclough Breakdown of academic impact, for papers by Elisa I. León Breakdown of academic impact, for papers by Marie Elise Tran Huu Dau Breakdown of academic impact, for papers by Kevin E. Henegar Breakdown of academic impact, for papers by M. T. NUNEZ Breakdown of academic impact, for papers by Brandon R. Smith Breakdown of academic impact, for papers by Irma Panfil Breakdown of academic impact, for papers by A. J. POSS Breakdown of academic impact, for papers by Yoshiya Amemiya
Rankless by CCL
2026